Menú
banner-risc-cardiovascular

Publicaciones

Clinical effectiveness of 13-valent and 23-valent pneumococcal vaccination among adults with immunocompromising conditions

E. SATUE-GRACIA, C. CABANES, A. VILA-ROVIRA, C. RODRIGUEZ-CASADO, O. OCHOA-GONDAR and A. VILA-CORCOLES
EUROPEAN RESPIRATORY JOURNAL. 2022 Sep 4; . doi:10.1183/13993003.congress-2022.263;

Ver más:
Prenatal and child vitamin D levels and allergy and asthma in childhood

J. SANGUESA, J. SUNYER, R. GARCIA-ESTEBAN, A. ABELLAN, A. ESPLUGUES, J. GARCIA-AYMERICH, M. GUXENS, A. IRIZAR, J. JULVEZ, L. LUQUE-GARCIA, A. RODRIGUEZ-DEHLI, A. TARDON, M. TORRENT, J. VIOQUE, M. VRIJHEID and M. CASAS
PEDIATRIC RESEARCH. 2022 Sep 3; . doi:10.1038/s41390-022-02256-9; PMID:36057646

Ver más:
Are we leaving someone behind? A critical discourse analysis on the understanding of public participation among people with experiences of participatory research

C. JACQUES-AVINO, E. ROEL, L. MEDINA-PERUCHA, J. MCGHIE, M. PONS-VIGUES, E. PUJOL-RIBERA, I. TURIEL and A. BERENGUERA
PLoS One. 2022 Sep 2; . doi:10.1371/journal.pone.0273727; PMID:36054140

Ver más:
Socioeconomic inequalities in COVID-19 vaccination and infection among adults living in urban areas of Catalonia, Spain: A population-based cohort study

E. ROEL, B. RAVENTOS, E. BURN, A. PISTILLO, D. PRIETO-ALHAMBRA and T. DUARTE-SALLES
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2022 Sep 1;

Ver más:
Development and external validation of a 1-and 5-year fracture prediction tool based on electronic medical records data: The EPIC risk algorithm

C. TEBE, N. PALLARES, C. REYES, C. CARBONELL-ABELLA, D. MONTERO-COROMINAS, E. MARTIN-MERINO, X. NOGUES, A. DIEZ-PEREZ, D. PRIETO-ALHAMBRA and D. MARTINEZ-LAGUNA
BONE. 2022 Sep 1; . doi:10.1016/j.bone.2022.116469; PMID:35691583

Ver más:
Secular trends of dispensed opioid prescriptions in Catalonia, Spain, 2007-19: A population-based cohort study of over 5 million individuals

J. XIE, V. STRAUSS, G. COLLINS, S. KHALID, A. DELMESTRI, A. TURKIEWICZ, M. ENGLUND, M. TADROUS, C. REYES and D. PRIETO-ALHAMBRA
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2022 Sep 1;

Ver más:
The impact of COVID-19 on population-level drug utilization of alendronate in five European databases

E. TAN, D. ROBINSON, A. JOEDICKE, M. SANCHEZ-SANTOS, M. MOSSEVELD, K. NIELSEN, C. REYES, A. VOSS, E. MARCONI, F. LAPI, J. REINOLD, K. VERHAMME, L. PEDERSEN, M. DE WILDE, M. RUIZ, M. ARAGON, P. BOSCO-LEVY, R. LASSALLE and D. PRIETO-ALHAMBRA
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2022 Sep 1;

Ver más:
The comparative risk of thrombosis with thrombocytopenia associated with different COVID-19 vaccines: International network cohort study including 5 European countries and the US

X. LI, E. BURN, T. DUARTE-SALLES, C. YIN, C. REICH, A. DELMESTRI, K. VERHAMME, P. RIJNBEEK and D. PRIETO-ALHAMBRA
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2022 Sep 1;

Ver más:
Overlap weighting versus inverse probability of treatment weighting: An empirical evaluation of propensity score methods to minimize confounding in COVID-19 vaccine effectiveness studies

A. JOEDICKE, M. CATALA, E. BURN, T. RATHOD-MISTRY, A. DELMESTRI and D. PRIETO-ALHAMBRA
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2022 Sep 1;

Ver más:
Flecainide and risk of skin cancer: A large population-based case-control study in Spain and Denmark

C. REYES, L. LEON-MUNOZ, A. PISTILLO, S. SCHMIDT, K. KRISTENSEN, A. POTTEGARD, C. HUERTA, T. DUARTE-SALLES and D. PUENTE
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2022 Sep 1;

Ver más: